Results 191 to 200 of about 15,557 (223)
Some of the next articles are maybe not open access.

IgA Vasculitis in Adults

Current Treatment Options in Rheumatology, 2018
Immunoglobulin A vasculitis (IgAV) is a small vessel vasculitis with skin, joint, gastrointestinal and renal manifestations. Our understanding of the natural history of this disease is limited due to the overall low incidence of IgAV in adults and a lack of consensus regarding diagnostic criteria.
Sarah M. Moran, Heather N. Reich
openaire   +1 more source

IgA nephropathy: A vasculitis?

Nephrology, 1997
Summary: Vasculitis is an inflammation of blood vessels which leads to necrosis and infarction of the endorgans involved. IgA nephropathy (IgAN) is the kidney‐limited expression of a single disease with Henoch‐Schonlei purpura as the systemic vasculitic form.
openaire   +1 more source

COVID-19 and IgA Vasculitis

The Journal of Rheumatology, 2022
Rujittika Mungmunpuntipantip   +1 more
openaire   +2 more sources

[Adult IgA vasculitis].

La Revue du praticien
ADULT IGA VASCULITIS. IgA vasculitis previously named rheumatoid purpura is a rare systemic vasculitis in adults involving small vessels and associated with the presence of immunoglobulin A deposits. IgA vasculitis is often triggerd by infections, taking medication and vaccination. It is characterised by the presence of vascular purpura associated with
Antoine, Hankard   +1 more
openaire   +1 more source

IgA Nephropathy and IgA Vasculitis

2022
Haresh Selvaskandan   +2 more
openaire   +1 more source

Global epidemiology of vasculitis

Nature Reviews Rheumatology, 2021
Richard A Watts   +2 more
exaly  

Large-vessel vasculitis

Nature Reviews Disease Primers, 2022
Maira Karabayas   +2 more
exaly  

Pulmonary-renal syndrome in IgA vasculitis

Kidney International, 2023
Sascha T. Bender   +2 more
openaire   +2 more sources

ANCA-associated vasculitis

Nature Reviews Disease Primers, 2020
Arthur Richard Kitching   +2 more
exaly  

IgA Vasculitis

2016
Roberta Fenoglio, Dario Roccatello
openaire   +1 more source

Home - About - Disclaimer - Privacy